Compare Manhattan Associates Inc (MANH) vs Nuvalent Inc (NUVL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manhattan Associates Inc vs Nuvalent Inc — how do they compare? Manhattan Associates Inc trades at $159.61 (market cap $9.79B), while Nuvalent Inc trades at $123.96 (market cap $9.81B). The key difference: Manhattan Associates Inc and Nuvalent Inc are close in size by market cap, and Nuvalent Inc is trading nearer its 52-week high, Manhattan Associates Inc nearer its low. Which is the better fit depends on your goals.
| MANH | NUVL | |
|---|---|---|
Market Cap | $9.79B | $9.81B |
Sector | Technology | Technology |
52-Week High | $227.94 | $123.96 |
52-Week Low | $120.88 | $72.16 |
Enterprise Value | $9.62B | $8.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Manhattan Associates Inc
Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.
Read more on MANH →About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →
